Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

How Many Chronic Myeloid Leukemia (CML) Patients in Chronic Phase (CP) Benefit from Treatment Free Remission? a Single Center Real-Life Experience

Mariella D'Adda, Valeria Cancelli, Sofia Terlizzi, Annamaria Pelizzari, Samantha Ferrari, Diego Bertoli, Chiara Bottelli, Nicola Bianchetti, Annalisa Peli, Ilaria Accarino, Carlotta Giupponi, Alessandra Tucci

Blood (2024) 144 (Supplement 1): 6612.

https://doi.org/10.1182/blood-2024-210714

Published: 2024

Journal Articles

Early Identification of Functional High Risk Multiple Myeloma Patients after Transplant with Diffusion-Weighted Whole-Body MRI: Predictive Role of Fat Fraction in Addition to RAC Score

Angelo Belotti, Barbara Frittoli, Sofia Terlizzi, Rossella Ribolla, Claudia Crippa, Chiara Saeli, Samantha Ferrari, Annalisa Peli, Nicola Bianchetti, Chiara Bottelli, Chiara Cattaneo, Carmela Carbone, Alessandro Gullino, Marco Chiarini, Viviana Giustini, Aldo Roccaro, Luigi Grazioli, Alessandra Tucci

Blood (2024) 144 (Supplement 1): 82.

https://doi.org/10.1182/blood-2024-198779

Published: 2024

Journal Articles

Failure to Achieve Sustained Imaging MRD Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Is Associated with Adverse Prognosis in Newly Diagnosed Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation Followed By Maintenance Therapy

Angelo Belotti, Rossella Ribolla, Claudia Crippa, Marco Chiarini, Viviana Giustini, Samantha Ferrari, Annalisa Peli, Chiara Cattaneo, Aldo Roccaro, Barbara Frittoli, Marta Salis, Luigi Grazioli, Giuseppe Rossi, Alessandra Tucci

Blood (2022) 140 (Supplement 1): 1140–1141.

https://doi.org/10.1182/blood-2022-157520

Published: 2022

Journal Articles

Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT)

Angelo Belotti, Rossella Ribolla, Alberta Villanacci, Marco Chiarini, Viviana Giustini, Giulia Vittoria Facchetti, Claudia Crippa, Valeria Cancelli, Samantha Ferrari, Annalisa Peli, Chiara Bottelli, Chiara Cattaneo, Chiara Saeli, Aldo M. Roccaro, Luigi Grazioli, Giuseppe Rossi, Alessandra Tucci

Blood (2021) 138 (Supplement 1): 1641.

https://doi.org/10.1182/blood-2021-147694

Published: 2021

Journal Articles

External Validation of Diffusion Weighted Whole Body MRI (DW-MRI) Response Assessment Category (RAC) Criteria Proposed By the Myeloma Response Assessment and Diagnosis System (MY-RADS) Imaging Recommendations: Prognostic Role of Imaging Response after Transplant in Multiple Myeloma and Comparison with MRD Evaluation By Flow Cytometry

Angelo Belotti, Rossella Ribolla, MD, Valeria Cancelli, MD, Alberta Villanacci, Valentina Angelini, Samantha Ferrari, Annalisa Peli, MD, Chiara Cattaneo, MD, Marco Chiarini, MSc, Luigi Grazioli, MD, Giuseppe Rossi, MD, Alessandra Tucci, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-135969

Published: 2020

Journal Articles

Five-Year Survival and Durability Results of the Phase 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine)As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Classic Hodgkin Lymphoma

Armando Santoro, MD, Rita Mazza, MD, Alessandro Pulsoni, MD, Alessandro Re, MD, Maurizio Bonfichi, MD, Vittorio Ruggero Zilioli, Flavia Salvi, Antonella Anastasia, MD, Stefano Luminari, MD, Manuel Gotti, MD, Annalisa Peli, MD, Anna Marina Liberati, MD, Nicola Di Renzo, MD, Luca Castagna, MD, Laura Giordano, Carmelo Carlo-Stella, MD

Blood (2018) 132 (Supplement 1): 1628.

https://doi.org/10.1182/blood-2018-99-118931

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous Therapy and Histological Subtype

Alessandro Re, MD, Nicola Bianchetti, Chiara Cattaneo, MD, Salvatore Casari, MD, Chiara Pagani, MD, Annalisa Peli, MD, Emanuele Focà, MD, Pierino ferremi Leali, MD, Camillo Almici, MD, Francesco Castelli, MD, Giuseppe Rossi

Blood (2018) 132 (Supplement 1): 2145.

https://doi.org/10.1182/blood-2018-99-116816

Published: 2018

Journal Articles

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Annalisa Peli, MD, Nicola Bianchetti, MD, Angela Passi, MD, Emanuele Focà, MD, Maria Miscio, Francesco Castelli, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 5223.

https://doi.org/10.1182/blood.V130.Suppl_1.5223.5223

Published: 2017

Journal Articles

Remarkable Clinical Efficacy, Stem Cell Mobilization Activity and Good Toxicity Profile of the Novel Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) Used As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Armando Santoro, MD, Rita Mazza, MD, Alessandro Pulsoni, MD, Alessandro Re, Maurizio Bonfichi, MD, Vittorio Ruggero Zilioli, MD, Flavia Salvi, MD, Antonella Anastasia, Stefano Luminari, MD, Manuel Gotti, MD, Annalisa Peli, Anna Marina Liberati, MD, Nicola Di Renzo, Luca Castagna, Laura Giordano, Carmelo Carlo-Stella, MD

Blood (2015) 126 (23): 581.

https://doi.org/10.1182/blood.V126.23.581.581

Published: 2015

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Guido Gini, MD, Mariagrazia Michieli, Bernardino Allione, Luisa Verga, MD, Caterina Bocci, Michele Spina, MD, Stefania Tamiazzo, Alessandra Bandera, Flavia Salvi, MD, Annalisa Peli, MD, Moira Micheletti, Camillo Almici, MD, Pierino Ferremi, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 2528.

https://doi.org/10.1182/blood.V124.21.2528.2528

Published: 2014

Journal Articles

High Dose Melphalan Followed By Autologous Stem Cell Transplant in AL Amyloidosis: a Single-Center Experience

Mariella D'Adda, MD, Francesca Schieppati, MD, Samantha Ferrari, MD, Claudia Crippa, MD, Annalisa Peli, MD, Alessandro Re, MD, Enrico Morello, MD, Paola Tozzi, PharmD, Vincenza Orlando, PharmD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 5909.

https://doi.org/10.1182/blood.V124.21.5909.5909

Published: 2014

Journal Articles

Plasmablastic Lymphoma Among HIV-Positive Patients: A Curable Entity? Results of a Single Centre's Experience

Chiara Cattaneo, MD, Alessandro Re, MD, Annalisa Peli, MD, Salvatore Casari, MD, Stefano Fogazzi, MD, Francesca Antoniazzi, MD, Chiara Pagani, MD, Francesca Schieppati, MD, Alfredo Scalzini, MD, Francesco Castelli, MD, Giuseppe Rossi

Blood (2012) 120 (21): 3640.

https://doi.org/10.1182/blood.V120.21.3640.3640

Published: 2012

Journal Articles

Bortezomib-Containing Regimens in the Treatment of AL Amyloidosis: A Single Center Experience

Alessandro Re, MD, Gina Gregorini, Annalisa Peli, MD, Matilde Nardi, Claudia Crippa, Samantha Ferrari, Laura Econimo, Chiara Cattaneo, Giovanni Cancarini, Giuseppe Rossi, MD

Blood (2011) 118 (21): 4614.

https://doi.org/10.1182/blood.V118.21.4614.4614

Published: 2011

Journal Articles

Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation

Cristina Skert, MD, Manuela Fogli, Simone Perucca, Simona Fiorentini, Emirena Garrafa, Jr., Carla Filì, Chiara Colombi, Annalisa Peli, MD, Cesare Bergonzi, Michele Malagola, Elisa Alghisi, Alessandro Turra, Arnaldo Caruso, Domenico Russo

Blood (2011) 118 (21): 4924.

https://doi.org/10.1182/blood.V118.21.4924.4924

Published: 2011

Journal Articles

Establishing a New Zebrafish Model to Study Malignant Transformation in Myeloproliferative Disorders

Elisa Alghisi, Michele Malagola, Cristina Santoriello, Cristina Skert, MD, Carla Filì, Cesare Bergonzi, Annalisa Peli, Alessandro Turra, Valeria Cancelli, Rossella Ribolla, Federica Cattina, MD, Marina Mione, Domenico Russo

Blood (2011) 118 (21): 4711.

https://doi.org/10.1182/blood.V118.21.4711.4711

Published: 2011

Journal Articles

Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study,

Cristina Skert, MD, Manuela Fogli, Simone Perucca, Simona Fiorentini, Emirena Garrafa, Jr., Carla Filì, Annalisa Peli, MD, Chiara Colombi, Cesare Bergonzi, Michele Malagola, Alessandro Turra, Arnaldo Caruso, Domenico Russo

Blood (2011) 118 (21): 4071.

https://doi.org/10.1182/blood.V118.21.4071.4071

Published: 2011

Journal Articles

Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Ongoing Results of a Prospective Study

Cristina Skert, MD, Emirena Garrafa, Jr, Manuela Fogli, Simona Fiorentini, Doris Ricotta, Luigi Caimi, Carla Filì, Annalisa Peli, Cesare Bergonzi, Michele Malagola, Martinelli Giovanni, MD, Ilaria Iacobucci, Alessandro Turra, Mario Arpinati, Federica Cattina, Arnaldo Caruso, Domenico Russo

Blood (2010) 116 (21): 4704.

https://doi.org/10.1182/blood.V116.21.4704.4704

Published: 2010

Journal Articles

Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study

Blood (2010) 116 (21): 4029.

https://doi.org/10.1182/blood.V116.21.4029.4029

Published: 2010

Journal Articles

Clinical and Biological EFFECTS of 5-Azacitidine FIVE Days/Monthly Schedule IN Symptomatic LOW-RISK (IPSS: 0-1) Myelodisplastic Patient.

Blood (2009) 114 (22): 4851.

https://doi.org/10.1182/blood.V114.22.4851.4851

Published: 2009

Journal Articles

Complete Haematological Response after Low Dose Rituximab in a Patient with Refractory Warm-Type Autoimmune Haemolytic Anaemia

Annalisa Peli, Michele Malagola, Carla Filí, Cristina Skert, Cesare Bergonzi, Francesco Zaja, Aldo M. Roccaro, MD, PhD, Domenico Russo

Blood (2008) 112 (11): 5376.

https://doi.org/10.1182/blood.V112.11.5376.5376

Published: 2008

NARROW

How Many Chronic Myeloid Leukemia (CML) Patients in Chronic Phase (CP) Benefit from Treatment Free Remission? a Single Center Real-Life Experience

Early Identification of Functional High Risk Multiple Myeloma Patients after Transplant with Diffusion-Weighted Whole-Body MRI: Predictive Role of Fat Fraction in Addition to RAC Score

Failure to Achieve Sustained Imaging MRD Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Is Associated with Adverse Prognosis in Newly Diagnosed Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation Followed By Maintenance Therapy

Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT)

Five-Year Survival and Durability Results of the Phase 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine)As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Classic Hodgkin Lymphoma

Autologous Stem Cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous Therapy and Histological Subtype

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Remarkable Clinical Efficacy, Stem Cell Mobilization Activity and Good Toxicity Profile of the Novel Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) Used As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

High Dose Melphalan Followed By Autologous Stem Cell Transplant in AL Amyloidosis: a Single-Center Experience

Plasmablastic Lymphoma Among HIV-Positive Patients: A Curable Entity? Results of a Single Centre's Experience

Bortezomib-Containing Regimens in the Treatment of AL Amyloidosis: A Single Center Experience

Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation

Establishing a New Zebrafish Model to Study Malignant Transformation in Myeloproliferative Disorders

Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study,

Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Ongoing Results of a Prospective Study

Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study

Clinical and Biological EFFECTS of 5-Azacitidine FIVE Days/Monthly Schedule IN Symptomatic LOW-RISK (IPSS: 0-1) Myelodisplastic Patient.

Complete Haematological Response after Low Dose Rituximab in a Patient with Refractory Warm-Type Autoimmune Haemolytic Anaemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only